Myungmoon Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Myungmoon Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
JW Life Science Corp
sales of 125.95 billion Korean Won [US$108.44 million]
Kukje Pharma Co Ltd
(117.64 billion Korean Won [US$101.29 million]
of which 89%
was Pharmaceutical), and
Sam Chun Dang Pharm Co Ltd
(132.06 billion Korean Won [US$113.71 million]
During the year ended December of 2015, sales at
Myungmoon Pharmaceutical Company Limited were 125.10 billion Korean Won (US$107.71 million).
increase of 18.7%
versus 2014, when the company's sales were 105.42 billion Korean Won.
This was the third consecutive year of growth at Myungmoon Pharmaceutical Company Limited.
Sales of Manufacturing and Sale of Pharmaceuticals saw an increase
19.7% in 2015, from
101.40 billion Korean Won to 121.41 billion Korean Won.
Not all segments of Myungmoon Pharmaceutical Company Limited experienced an increase in sales in 2015:
sales of Severce Segment fell 8.0% to 3.70 billion Korean Won.
(However, this segment's sales were only a very small portion of the company's overall sales).